Establishment of a prognosis predictive model for liver cancer based on expression of genes involved in the ubiquitin-proteasome pathway

Figure 3 Correlation of expression levels of ATG10, PSMA8, PSMB2, USP17L2, and USP8 and risk score with clinical parameters. A-C: Gene expression and risk score between genders; D-G: Gene expression and risk score among T stages; H: Risk score among N stages; I-L: Gene expression and risk score among clinical stages; M: Correlation of gene expression levels and risk score with biochemical indexes; N: Correlation of gene expression levels and risk score with postoperative recurrence in liver cancer, with a hazard ratio (HR) > 1 referring to a positive correlation and HR < 1 referring to a negative correlation. P < 0.05 indicated statistical significance. HR: Hazard ratio.